protein disulfide isomerase inhibitors (University of Southern California)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug Nameprotein disulfide isomerase inhibitors (University of Southern California)

Drug Alias NamePDI inhibitors (University of Southern California)propynoic acid carbamoyl methyl amide therapeutics (University of Southern California)PACMA therapeutics (University of Southern California)PACMA-31

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionProtein disulfide isomerase inhibitors

TargetsProtein disulfide isomerase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Southern California

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity Of Southern California

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A